1. Loss-of-Function Variants in the Tumor-Suppressor Gene PTPN14 Confer Increased Cancer Risk
- Author
-
Unnur Thorsteinsdottir, Asgeir Sigurdsson, Bjarni V. Halldorsson, Asmundur Oddsson, Kari Stefansson, Tomas Thor Agustsson, Hannes P. Eggertsson, Rafn Benediktsson, Gudmar Thorleifsson, Páll Melsted, Thorunn Rafnar, Arni Kristjansson, Patrick Sulem, Lilja Stefansdottir, Karl Olafsson, Kristjan Norland, Julius Gudmundsson, Jón Ólafsson, Laufey Tryggvadottir, Kavita Y. Sarin, Solvi Rognvaldsson, Gardar Sveinbjornsson, Hakon Jonsson, Arnaldur Gylfason, Sigurjon A. Gudjonsson, Sigrun H. Lund, Kristin Thorisdottir, Daniel F. Gudbjartsson, Florian Zink, Aslaug Jonasdottir, Jon G. Jonasson, Evgenia Mikaelsdottir, Bardur Sigurgeirsson, Thorhildur Ólafsdóttir, Valgerdur Steinthorsdottir, Pall I. Olason, Snaedis Kristmundsdottir, Run Fridriksdottir, and Simon N. Stacey
- Subjects
0301 basic medicine ,Genetics ,Cancer Research ,Cancer-Predisposing Gene ,Tumor suppressor gene ,Cancer ,Locus (genetics) ,Genome-wide association study ,Biology ,medicine.disease ,medicine.disease_cause ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Oncology ,030220 oncology & carcinogenesis ,Genotype ,medicine ,Basal cell carcinoma ,Carcinogenesis - Abstract
The success of genome-wide association studies (GWAS) in identifying common, low-penetrance variant-cancer associations for the past decade is undisputed. However, discovering additional high-penetrance cancer mutations in unknown cancer predisposing genes requires detection of variant-cancer association of ultra-rare coding variants. Consequently, large-scale next-generation sequence data with associated phenotype information are needed. Here, we used genotype data on 166,281 Icelanders, of which, 49,708 were whole-genome sequenced and 408,595 individuals from the UK Biobank, of which, 41,147 were whole-exome sequenced, to test for association between loss-of-function burden in autosomal genes and basal cell carcinoma (BCC), the most common cancer in Caucasians. A total of 25,205 BCC cases and 683,058 controls were tested. Rare germline loss-of-function variants in PTPN14 conferred substantial risks of BCC (OR, 8.0; P = 1.9 × 10−12), with a quarter of carriers getting BCC before age 70 and over half in their lifetime. Furthermore, common variants at the PTPN14 locus were associated with BCC, suggesting PTPN14 as a new, high-impact BCC predisposition gene. A follow-up investigation of 24 cancers and three benign tumor types showed that PTPN14 loss-of-function variants are associated with high risk of cervical cancer (OR, 12.7, P = 1.6 × 10−4) and low age at diagnosis. Our findings, using power-increasing methods with high-quality rare variant genotypes, highlight future prospects for new discoveries on carcinogenesis. Significance: This study identifies the tumor-suppressor gene PTPN14 as a high-impact BCC predisposition gene and indicates that inactivation of PTPN14 by germline sequence variants may also lead to increased risk of cervical cancer.
- Published
- 2021